Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Nature study: A novel family of antibiotics against tuberculosis and salmonella target pathways active in cancer.

29.11.2007
Researchers have discovered new ways to fight bacterial infections including extensively drug-resistant tuberculosis. The work will be published in the journal Nature on 29 November.

The research led by Dr. Jacques Neefjes from the Netherlands Cancer Institute, with collaboration of Dr. Tom Ottenhoff from the Leiden University Medical Center and Dr. Hermen Overkleeft from the Leiden University Institute of Chemistry, shows that pathways commonly found in cancer cells are also modified by pathogenic bacteria. It is likely that the discovery will lead to new drugs against cancer and tuberculosis.

The Dutch groups have developed chemical compounds which can greatly reduce the bacterial loads within infected human cells (such as Mycobacteria tuberculosis and Salmonella typhimurium). The chemical compounds they generated inhibit PKB/Akt1 enzymes in cells, enzymes which are also upregulated in various cancers. It appears that pathogenic bacteria seize control of PKB/Akt1 to evade immune degradation. Inhibiting the PKB/Akt1 enzyme thus forces the bacteria back into the degradation pathway to be eliminated.

PKB/Akt1 is the focus of cancer research at present since it has been shown to stimulate the growth of cancer cells. Discovering that bacteria utilize PKB/Akt1 in order to survive, sheds some light onto mechanisms that lead to cancer development following chronic bacterial infections in some patients.

“Many anti-cancer drugs originate from antibiotic discovery attempts. Pharmaceutical companies are currently developing specific PKB/Akt1 inhibitors. It is feasible that these inhibitors may well work against bacterial infections also”, says Dr. Jacques Neefjes.

This month, the World Health Organization (WHO) sounded the alarm because of a severe increase in multi and extensively drug-resistant (MDR and XDR) Mycobacterium tuberculosis infected countries. For MDR and XDR infected patients, current antibiotic therapy is inefficient or ineffective. New antibiotic therapies are therefore urgently needed.

This research was supported by the Netherlands Organization for Scientific Research (NWO), the Dutch Cancer Society (KWF) and an EEC network grant.

Frederique Melman | alfa
Further information:
http://www.nki.nl/Research/

More articles from Studies and Analyses:

nachricht The Great Unknown: Risk-Taking Behavior in Adolescents
19.01.2017 | Max-Planck-Institut für Bildungsforschung

nachricht A sudden drop in outdoor temperature increases the risk of respiratory infections
11.01.2017 | University of Gothenburg

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Quantum optical sensor for the first time tested in space – with a laser system from Berlin

For the first time ever, a cloud of ultra-cold atoms has been successfully created in space on board of a sounding rocket. The MAIUS mission demonstrates that quantum optical sensors can be operated even in harsh environments like space – a prerequi-site for finding answers to the most challenging questions of fundamental physics and an important innovation driver for everyday applications.

According to Albert Einstein's Equivalence Principle, all bodies are accelerated at the same rate by the Earth's gravity, regardless of their properties. This...

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

Tracking movement of immune cells identifies key first steps in inflammatory arthritis

23.01.2017 | Health and Medicine

Electrocatalysis can advance green transition

23.01.2017 | Physics and Astronomy

New technology for mass-production of complex molded composite components

23.01.2017 | Process Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>